Renaissance Technologies (RenTech)'s LXEO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 217,772 shares of Lexeo Therapeutics, Inc. (LXEO) worth $2.16 M, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 6 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in LXEO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 85,900 shares. Largest reduction occurred in Q2 2024, reducing 14,576 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Lexeo Therapeutics (LXEO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lexeo Therapeutics (LXEO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +68,472 | Add 45.86% | 217,772 | $9.93 |
| Q3 2025 | +43,100 | Add 40.58% | 149,300 | $6.64 |
| Q2 2025 | +85,900 | Add 423.15% | 106,200 | $4.02 |
| Q1 2025 | +20,300 | New Buy | 20,300 | $3.47 |
| Q2 2024 | -14,576 | Sold Out | 0 | $0.00 |
| Q1 2024 | +14,576 | New Buy | 14,576 | $15.71 |
Renaissance Technologies (RenTech)'s Lexeo Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Lexeo Therapeutics, Inc. (LXEO) in Q1 2024, acquiring 14,576 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Lexeo Therapeutics, Inc. (LXEO) for 6 quarters since Q1 2024.
Renaissance Technologies (RenTech)'s largest addition to Lexeo Therapeutics, Inc. (LXEO) was in Q2 2025, adding 106,200 shares worth $426,924.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 217,772 shares of Lexeo Therapeutics, Inc. (LXEO), valued at approximately $2.16 M.
As of the Q4 2025 filing, Lexeo Therapeutics, Inc. (LXEO) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Lexeo Therapeutics, Inc. (LXEO) was 217,772 shares, as reported at the end of Q4 2025.